Results 301 to 306 of about 136,040,587 (306)

Top bar navigation

Frontiers in Pharmacology, 2018
Michael A Hill, Zheran Liu, Mao Luo
exaly  

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.

Thrombosis Research, 2012
Britt Van De Craen, P. Declerck, A. Gils
semanticscholar   +1 more source

Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity

Thrombosis Research, 2012
Francisco España, Juan Gilabert-Estellés, Aitana Braza-Boïls   +2 more
exaly  

Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity

Thrombosis Research, 2006
Francisco España, Carlos Vázquez, Justo Aznar   +2 more
exaly  

A redox‐sensitive loop regulates plasminogen activator inhibitor type 2 (PAI‐2) polymerization

EMBO Journal, 2003
Malgorzata Wilczynska, Tor Ny
exaly  

Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis

Journal of Thrombosis and Haemostasis, 2008
exaly